Diadema Partners »

Urogen Pharma shares owned by Diadema Partners

Quarter-by-quarter ownership of Urogen Pharma (URGN) shares owned by Diadema Partners from 13F filings

Historical chart of Diadema Partners investment in Urogen Pharma

Tip: Access up to 7 years of quarterly data

All positions including Urogen Pharma held by Diadema Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Urogen Pharma by Diadema Partners

Quarter filed Position value Share count Share price at filing
2025-09-30 $1.8M 90k 19.95

More positions owned by Diadema Partners

Jazz Pharmaceuticals Shs Usd (JAZZ)
Soleno Therapeutics (SLNO)
Uniqure Nv SHS Put Option (QURE)
Regeneron Pharmaceuticals (REGN)
Viking Therapeutics (VKTX)
Bristol Myers Squibb (BMY)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
BioMarin Pharmaceutical (BMRN)
Avidity Biosciences Ord (RNA)
Agios Pharmaceuticals Call Option (AGIO)
Ultragenyx Pharmaceutical (RARE)
Incyte Corporation Call Option (INCY)
Intellia Therapeutics Call Option (NTLA)
Vaxcyte (PCVX)
Eli Lilly & Co. Put Option (LLY)

View all positions for Diadema Partners

Top funds holding Urogen Pharma

Rtw Investments
Paradigm Biocapital Advisors
Toronto-Dominion Bank
BlackRock
Morgan Stanley
Leucadia National Corporation
Silverarc Capital Management
Millennium Management
Acorn Capital Advisors
SG Americas Securities
Menora Mivtachim Holdings
Caption Management
Tang Capital Management
D. E. Shaw & Co
State Street Corporation

View all funds holding Urogen Pharma